Source: CompanyNews HQ

Pyxant: Bird & Bird Advises ArchiMed in Three Acquisitions

ird & Bird represented ArchiMed, a European healthcare-focused private equity fund, in three simultaneous acquisitions that will create an innovative market leader in the bioanalytical market:

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Maurice Gaubatz's photo - Founder & CEO of Pyxant

Founder & CEO

Maurice Gaubatz

CEO Approval Rating

84/100

Read more